Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2909841

N.Nc1nc(CCCn2cc(C(=O)N3CCCCCC3)c(-c3ccc(-n4ccnc4)cc3)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HTT P42858 2/20 0.34
MAPK1 P28482 1/20 0.34
HPGD P15428 1/20 0.33
RECQL P46063 1/20 0.33
FNTA P49354 1/20 0.32
FNTB P49356 1/20 0.32
LSS P48449 1/20 0.32
POLB P06746 1/20 0.31
CDK1 P06493 1/20 0.31
GSK3A P49840 1/20 0.31
GSK3B P49841 1/20 0.31
THRA P10827 1/20 0.31
THRB P10828 1/20 0.31
FAAH O00519 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL2911566 0.99 ALDH1A1 (0.33) ALDH1A1MAPTSMN1; SMN2L3MBTL1MEN1
Ammonia Solution, Strong SCHEMBL2911403 0.93 FNTA (0.37) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
Ammonia Solution, Strong SCHEMBL2912722 0.88 GPR119 (0.33)
Ammonia Solution, Strong SCHEMBL2903756 0.88 GPR119 (0.33)
SCHEMBL2909976 0.80 GSK3A (0.39) ALDH1A1MAPTSMN1; SMN2L3MBTL1MEN1
SCHEMBL2906860 0.79 GSK3A (0.39) ALDH1A1MAPTSMN1; SMN2L3MBTL1MEN1
SCHEMBL2911578 0.77 GSK3A (0.38) ALDH1A1MAPTSMN1; SMN2L3MBTL1MEN1
SCHEMBL2904171 0.77 GSK3A (0.38) ALDH1A1MAPTSMN1; SMN2L3MBTL1MEN1
SCHEMBL2909662 0.76 GSK3A (0.44) ALDH1A1MAPTSMN1; SMN2L3MBTL1MEN1
SCHEMBL2904415 0.74 CDK1 (0.36) CDK1GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed